메뉴 건너뛰기




Volumn 84, Issue 4, 1999, Pages 1268-1276

Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; NANDROLONE DECANOATE;

EID: 0033340035     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.4.1268     Document Type: Article
Times cited : (86)

References (45)
  • 16
    • 0032558803 scopus 로고    scopus 로고
    • Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients
    • (1998) AIDS , vol.12
    • Walli, R.1    Herfort, O.2    Michl, G.M.3
  • 26
    • 0029899784 scopus 로고    scopus 로고
    • Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection
    • (1996) AIDS , vol.10 , pp. 745-752
    • Gold, J.1    High, H.A.2    Li, Y.3
  • 29
    • 0021879424 scopus 로고
    • The effect of anabolic steroids on lean body mass: The dose response curve
    • (1985) Metabolism , vol.34 , pp. 571-573
    • Forbes, G.B.1
  • 30
    • 0033048271 scopus 로고    scopus 로고
    • Short-term progressive resistance training increases strength and lean body mass in adults infected with human irmmunodeficiency virus
    • (1999) AIDS , vol.13 , pp. 231-239
    • Roubenoff, R.1    McDermott, A.2    Weiss, L.3
  • 45
    • 0038467838 scopus 로고    scopus 로고
    • Measurement of body weight and body cell mass in patients receiving highly active antiretroviral thearpy (HAART)
    • Proc of the Interscience Conference on Antimicrobial Agents and Chemotherapy. (Abstract 17-I)
    • (1997)
    • Berger, D.1    Bucher, G.2    Cimoch, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.